Qian(Quincy) Song is a seasoned professional in the field of biochemistry and chemistry with extensive research expertise spanning various institutions. Qian served as a Postdoctoral Researcher at Stanford University, focusing on targeted delivery methods for autoimmune disease treatments, and has held multiple roles at TrueBinding, including Principal Scientist and Group Lead for Target Validation. Currently, Qian is the Associate Director at Jiangsu Hengrui Pharmaceuticals Co., Ltd. Previous experience includes a Postdoctoral Research Fellow at Northwestern University, where projects emphasized RNAi therapeutics in skin tumors, a Research Assistant at Washington University in St. Louis, and a Research Assistant at Peking University. Qian obtained a Ph.D. from Washington University in St. Louis and a Bachelor's degree in Chemistry from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices